Esanum is the medical platform on the Internet. Here, doctors have the opportunity to get in touch with a multitude of colleagues and to share interdisciplinary experiences. Discussions include both cases and observations from practice, as well as news and developments from everyday medical practice.
esanum ist die Ärzteplattform im Internet. Hier haben Ärzte die Möglichkeit, mit einer Vielzahl von Kollegen in Kontakt zu treten und interdisziplinär Erfahrungen auszutauschen. Diskussionen umfassen sowohl Fälle und Beobachtungen aus der Praxis, als auch Neuigkeiten und Entwicklungen aus dem medizinischen Alltag.
Esanum est la plate-forme médicale sur Internet. Ici, les médecins ont la possibilité de prendre contact avec Une multitude de collègues et de partager des expériences interdisciplinaires. Les discussions portent à la fois sur les Observations de la pratique, ainsi que des nouvelles Et les développements de la pratique médicale quotidienne.
Osteoarthritis (OA) is no longer seen as a degenerative disease. Low grade chronic inflammatory processes lead to cartilage damage.
Researchers have long noted links between cancer and autoimmune rheumatic diseases. Naturally occurring or pharmacologically induced anti-tumor immune responses may lead to autoimmune diseases.
Treatment with the IL17 inhibitor secukinumab inhibits radiographic progression in patients with psoriatic arthritis: this promising result could be shown in the large FUTURE 5 trial.
In a post hoc analysis of two phase 3 trials, therapy with Sarilumab lowered HbA1c concentrations in diabetic and nondiabetic rheumatoid arthritis (RA) patients.
A study showed that low levels of vitamin D were associated with higher rates of end-stage renal disease in patients with Systemic Lupus Erythematosus (SLE).
According to new research findings, infants of rheumatoid arthritis (RA) patients using a biologic during pregnancy do not have an elevated risk of infections.
Professor Jasmohan Bajaj talks about the overuse and misuse of antibiotics and how this will cause an international pandemic, if the "reset-button" to deescalate the use of antibiotics is not pressed soon.
Professor Subrata Ghosh summarises the key findings of the ICONIC-study, which is the largest ongoing observational study on the burden of adult ulcerative colitis in patients under routine care. It comprises 1.816 enrolled patients in 33 countries throughout the globe.
Crohn’s disease (CD) is a progressive disorder and the achievement of mucosal healing lowers the risk of necessary surgery, according to Julián Panés (Spain).
As early as week 2, patient-reported symptomatic improvements were achieved among UC patients treated with vedolizumab – including a combined reduction in defecation frequency and rectal blood loss. These findings underline the fast action of vedolizumab in treating UC, particularly when it is used as a first-line biological therapy.